人工智能在心血管医学中的伦理与实施框架
A translational bioethical & implementation framework for the use of artificial intelligence in cardiovascular medicine
本文讨论了人工智能在心血管医学中的伦理问题及其监管要求,提出了从算法设计到工具使用各环节的治理原则,旨在确保人工智能在患者护理中的负责任应用。作者指出,当前监管存在不足,需进一步完善以保障患者权益。
- Review
- Open access
- Published: 03 November 2026
- Camryn J. Kimura1,
- Keshav R. Nayak2,
- Sam W. McGrath3,
- Leeda Rashid4 &
- …
- Sanjeev P. Bhavnani ORCID: orcid.org/0000-0001-8161-95235,6
npj Cardiovascular Health (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Artificial intelligence (AI) in cardiology is rapidly expanding, but enthusiasm for anticipated benefits should be balanced by a more critical inspection of ethical concerns. In this state-of-the-art review, we discuss the four pillars of bioethics and their overlap with AI regulatory requirements to identify the potential gain and challenges, for both cardiologists and cardiac patients alike, in integrating AI-based clinical tools within various aspects and settings of care. By investigating the current gaps in regulatory oversight and illustrating hypothetical case scenarios, we aim to locate points of weakness along the course of implementation, from algorithm design to tool misuse, which endanger autonomy, beneficence, nonmaleficence, and justice if AI production proceeds without further attention into safeguard development. Finally, we propose governance principles and priorities for AI in cardiovascular medicine to highlight areas where a bioethical-regulatory framework needs to be adapted in order to ensure responsible use of AI in patient care.
Funding
No funding was received for this research.
Author information
Authors and Affiliations
The Warren Alpert Medical School of Brown University, Providence, RI, USA
Camryn J. Kimura
Department of Cardiology at Scripps Mercy Hospital, San Diego, CA, USA
Keshav R. Nayak
Department of Philosophy, Fordham University, New York City, NY, USA
Sam W. McGrath
Prime Years Concierge Care, San Francisco, CA, USA
Leeda Rashid
Division of Cardiology at Scripps Clinic Medical Group, San Diego, CA, USA
Sanjeev P. Bhavnani
Systems Intelligence & Practice Transformation Laboratory, San Diego, CA, USA
Sanjeev P. Bhavnani
Authors
- Camryn J. Kimura
- Keshav R. Nayak
- Sam W. McGrath
- Leeda Rashid
- Sanjeev P. Bhavnani
Corresponding author
Correspondence to Camryn J. Kimura.
Ethics declarations
Competing interests
L.R. is a former senior medical office at the U.S. Food and Drug Administration, has served as a consultant to PrecXI Med, and serves on the AI advisory board of the Healthcare Information and Management Systems Society. S.P.B. is a special government employee and former senior medical officer at the U.S. Food & Drug Administration; has served as a consultant or is on the advisory board of RCE.AI, Conneqt Health, Samsung Research America; has been on the speaker’s bureau of General Electric Healthcare and Pfizer Patient Advocacy; serves on the medical advisory board of the Cardiac Science Research Consortium, Heart Failure Society of America, and the Healthcare Information and Management Systems Society. S.P.B is an Associate Editor at npj Cardiovascular Health. S.P.B. was not involved in the journal’s review of, or decisions related to, this manuscript. The information in this manuscript does not reflect the opinions of the FDA or represent the policy or regulatory requirements of the Agency. The opinions in this manuscript are those of the authors. The other authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kimura, C.J., Nayak, K.R., McGrath, S.W. et al. A translational bioethical & implementation framework for the use of artificial intelligence in cardiovascular medicine. npj Cardiovasc Health (2026). https://doi.org/10.1038/s44325-026-00159-w
Received: 31 December 2025
Accepted: 03 October 2026
Published: 03 November 2026
DOI: https://doi.org/10.1038/s44325-026-00159-w
来源:Nature 健康护理主题 · nature.com